BioDelivery Sciences International Director Samuel Sears Jr Sells 2,000 Shares (BDSI)
BioDelivery Sciences International (NASDAQ:BDSI) Director Samuel Sears, Jr. sold 2,000 shares of BioDelivery Sciences International stock in a transaction dated Wednesday, September 11th. The stock was sold at an average price of $5.37, for a total value of $10,740.00. Following the completion of the sale, the director now directly owns 23,853 shares in the company. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.
A number of analysts have recently weighed in on BDSI shares. Analysts at Roth Capital raised their price target on shares of BioDelivery Sciences International (NASDAQ:BDSI) from $7.00 to $8.50 in a research note to investors on Monday, August 12th. Analysts at Ladenburg Thalmann raised their price target on shares of BioDelivery Sciences International (NASDAQ:BDSI) from $7.25 to $9.00 in a research note to investors on Friday, August 2nd. They now have a “buy” rating on the stock.
BioDelivery Sciences International (NASDAQ:BDSI) traded down 1.32% on Thursday, hitting $5.22. The stock had a trading volume of 136,433 shares. BioDelivery Sciences International has a 52 week low of $3.52 and a 52 week high of $6.89. The stock’s 50-day moving average is $4.69 and its 200-day moving average is $4.55. The company’s market cap is $198.5 million.
BioDelivery Sciences International, Inc (NASDAQ:BDSI) is a specialty pharmaceutical company.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.